Swiss Hemophilia Registry

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02512250

Enrollment

900

Registered

2015-07-30

Start date

2015-05-31

Completion date

2025-12-31

Last updated

2022-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophilia and Other Severe Bleeding Disorders

Brief summary

The Swiss Hemophilia Registry will collect data on the prophylactic and therapeutic use of factor concentrates in patients with hemophilia and other severe bleeding disorders in Switzerland.

Interventions

OTHERRegistry

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Diagnosis of hemophilia or other severe bleeding disorders. Signed inform consent

Exclusion criteria

None

Design outcomes

Primary

Measure	Time frame	Description
Number of incidence of disease and inhibitor development	1 year	Demographics, Comorbidties, factor consumption for prophylaxis, bleeding and surgery, inhibito develeopment

Countries

Switzerland

Contacts

Primary ContactManuela Albisetti, MD

manuela.albisetti@kispi.uzh.ch+41 44 266 71 38

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026